Use of bromelain proteases for inhibiting blood coagulation

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/48 (2006.01) A61P 7/02 (2006.01)

Patent

CA 2333252

The invention relates to the use of bromelain proteases for inhibiting the blood coagulation system, notably for stimulating plasmin production, inhibiting fibrin production and inhibiting the adhesion of human thrombocytes to endothelial cells. The basic proteases, which can be isolated from pure bromelain, have proved to be especially suitable proteases.

L'invention concerne l'utilisation de bromélaïne protéases pour inhiber le système de coagulation du sang, notamment pour stimuler la formation de plasma, pour inhiber la formation de fibrine et l'adhésion de thrombocytes humains sur des cellules endothéliales. Les protéases basiques, pouvant être isolées à partir de la bromélaïne pure, se sont avérées des protéases particulièrement appropriées.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of bromelain proteases for inhibiting blood coagulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of bromelain proteases for inhibiting blood coagulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of bromelain proteases for inhibiting blood coagulation will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1567628

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.